Kara Rzasa

Ackerman lab

I received my Bachelor's in Biochemistry, Molecular and Cellular Biology from the University of New Hampshire in 2019. From there I began working in Boston, MA at the Broad Institute of MIT and Harvard in the Infectious Disease and Microbiome Program. My work has been largely focused on microbial genetics and the study of the microbiome. I am interested in pursuing research related to host-microbe interactions. Outside of the lab, I love fishing, hiking, reading as well as spoiling my two dogs. 

Contact

Kara.M.Rzasa.GR@dartmouth.edu
HB Hinman Box 7560

Selected Publications

  • Scheid JF, Barnes CO, Eraslan B, Hudak A, Keeffe JR, Cosimi LA, Brown EM, Muecksch F, Weisblum Y, Zhang S, Delorey T, Woolley AE, Ghantous F, Park SM, Phillips D, Tusi B, Huey-Tubman KE, Cohen AA, Gnanapragasam PNP, Rzasa K, Hatziioanno T, Durney MA, Gu X, Tada T, Landau NR, West AP Jr, Rozenblatt-Rosen O, Seaman MS, Baden LR, Graham DB, Deguine J, Bieniasz PD, Regev A, Hung D, Bjorkman PJ, Xavier RJ. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV. Cell. 2021 Jun 10;184(12):3205-3221.e24. doi: 10.1016/j.cell.2021.04.032. Epub 2021 Apr 24. PMID: 34015271; PMCID: PMC8064835.

    Erica N. Parker, Brett N. Cain, Behnoush Hajian, Rebecca J. Ulrich, Emily J. Geddes, Sulyman Barkho, Hyang Yeon Lee, John D. Williams, Malik Raynor, Diana Caridha, Angela Zaino, Mrinal Shekhar, Kristen A. Muñoz, Kara M. Rzasa, Emily R. Temple, Diana Hunt, Xiannu Jin, Chau Vuong, Kristina Pannone, Aya M. Kelly, Michael P. Mulligan, Katie K. Lee, Gee W. Lau, Deborah T. Hung, and Paul J. Hergenrother. An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections. ACS Central Science 2022 8 (8), 1145-1158. DOI: 10.1021/acscentsci.2c00598